Huart, Justine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de néphrologie
Persu, A.; Service de cardiologie, département Cardiovasculaire, Cliniques Universitaires Saint-Luc, université Catholique de Louvain, Bruxelles, Belgium ; Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique, université Catholique de Louvain, Bruxelles, Belgium
Language :
French
Title :
L'adhésion thérapeutique dans l'hypertension artérielle résistante
Publication date :
April 2022
Journal title :
Archives des Maladies du Coeur et des Vaisseaux. Pratique
Vrijens, B., De Geest, S., Hughes, D.A., et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73 (2012), 691–705.
Blaschke, T.F., Osterberg, L., Vrijens, B., Urquhart, J., Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 52 (2012), 275–301.
Eskås, P.A., Heimark, S., Eek Mariampillai, J., Larstorp, A.C.K., Fadl Elmula, F.E.M., Høieggen, A., Adherence to medication and drug monitoring in apparent treatment-resistant hypertension. Blood Press 25 (2016), 199–205.
Lane, D., Lawson, A., Burns, A., et al. Nonadherence in hypertension: how to develop and implement chemical adherence testing. Hypertens (Dallas, Tex 1979) 79 (2022), 12–23.
Ruzicka, M., Hiremath, S., Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension. Curr Hypertens Rep 17 (2015), 1–8.
Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., Burnier, M., Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336 (2008), 1114–1117.
Burnier, M., Wuerzner, G., Struijker-Boudier, H., Urquhart, J., Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertens (Dallas, Tex 1979) 62 (2013), 218–225.
Gupta, P., Patel, P., Štrauch, B., et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension 69 (2017), 1113–1120.
Choudhry, N.K., Kronish, I.M., Vongpatanasin, W., et al. Medication adherence and blood pressure control: a scientific statement From the American Heart Association. Hypertension 79 (2022), e1–e14.
Burnier, M., Prejbisz, A., Weber, T., et al. Hypertension healthcare professional beliefs and behaviour regarding patient medication adherence: a survey conducted among European Society of Hypertension Centres of Excellence. Blood Press 30 (2021), 282–290.
Corrao, G., Parodi, A., Zambon, A., et al. Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens 28 (2010), 1584–1590.
Williams, B., Mancia, G., Spiering, W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39 (2018), 3021–3104.
Parthan, A., Vincze, G., Morisky, D.E., Khan, Z.M., Strategies to improve adherence with medications in chronic, “silent” diseases representing high cardiovascular risk. Expert Rev Pharmacoeconomics Outcomes Res 6 (2006), 325–336.
Corrao, G., Parodi, A., Nicotra, F., et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 29 (2011), 610–618.
Berra, E., Azizi, M., Capron, A., et al. Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension. Hypertension 68 (2016), 297–306.
Pucci, M., Martin, U., Detecting non-adherence by urine analysis in patients with uncontrolled hypertension: rates, reasons and reactions. J Hum Hypertens 31 (2017), 253–257.
Durand, H., Hayes, P., Morrissey, E.C., et al. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. J Hypertens 35 (2017), 2346–2357.
Brinker, S., Pandey, A., Ayers, C., et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol 63 (2014), 834–835.
Pandey, A., Raza, F., Velasco, A., et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens, 9, 2015 [420-6.e2].
Gupta, P., Patel, P., Štrauch, B., et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension 70 (2017), 1042–1048.
Petit, G., Berra, E., Georges, C.M.G., et al. Impact of psychological profile on drug adherence and drug resistance in patients with apparently treatment-resistant hypertension. Blood Press 27 (2018), 358–367.
Pappaccogli, M., Di Monaco, S., Georges, C.M.G., et al. Predictors of blood pressure control in patients with resistant hypertension after intensive management in two expert centres: the Brussels-Torino experience. Blood Press 28 (2019), 336–344.
